Testimonials

Since Tri-Solfen^® was commercially launched, over 150 million lambs have been treated and over 80% of Australian wool growers are now using Tri-Solfen for their sheep. Here’s what some of them have to say…

‘We have used pain relief for two years now and seen real production gains. We are concerned for the welfare of our animals and will continue to use pain relief to ensure they get the best care.’

Clinton Wise– Wililoo Merino Stud, Woodanilling, W.A.

'It easy to see the difference pain relief makes. Before, lambs would walk away hunched up, even taking a couple of hours to walk back to the paddock. Now they run straight back to Mum and start suckling,” says Rod. “My wool is now sold under the Better Choices brand. I see this as a definite advantage. I think it will be an advantage in the long run, to both me and the industry as a whole.'

Rod Miller– Glenpaen Merino Stud, Horsham, Vic

'After being treated with pain relief my lambs were more content and less stressed. As farmers we are sincere in looking after the welfare of our animals and using pain relief demonstrates this.'

Richard Coole– Frankland, W.A.

'We have been using pain relief for the past three years. We’re impressed by reduced bleeding in the mulesing wound immediately after application. Lambs run straight back to find the ewe, which has dramatically reduced our mortality rates. Flock management, post lamb marking is easier due to the effect of pain relief and the scab healing faster.'

Ryan & Malcom O’Dea– Peepingee Merino Stud, Narrogin, W.A.

'Using pain relief eases the stress and allows lambs to mother up and move back to the paddock easier with faster weight gains.'

Kent Lummis– Waverley Downs, Gilgandra, NSW

Country	Species	Patent
Australia	Sheep	Granted
Australia	Horses, Dogs, Lab animals	Granted
Australia	Cattle	Granted
Australia	Humans	Granted
New Zealand	Sheep, Cattle	Granted
New Zealand	Horses, Dogs, Lab animals	Granted
EU	Humans	Granted
EU	Pig, Sheep, Cattle	Granted
USA	Dogs, Horses, Lab animals	Granted
USA	Humans	Granted
USA	Pig, Sheep, Cattle	Granted
Canada	Horses, Dogs, Lab animals	Granted
Canada	Cattle, Pig	Granted
Canada	Humans	Granted

Advisory Board

Ian Page

Non-Executive Director

Ian is Chief Executive Officer of Dechra Pharmaceuticals, which has a 33% shareholder in Medical Ethics. He joined National Veterinary Services, Dechra’s former services business in 1989 and joined the Board of Dechra in 1997. In October 2010, Ian was appointed as Non-Executive Chairman of Sanford DeLand Asset Management.

Dr Chris Roberts

Human Wound and Regulatory Advisor

Chris has over 20 years’ line management experience of heading clinical research teams. He was previously global head of Smith & Nephew clinical support and market development, where he managed global clinical Phase II and III programmes in the management of venous and pressure ulcers.

Lieutenant Colonel Professor Steven Jeffery

Medical Specialist Advisor

Steve has over 15 years’ experience in military plastic surgery. In 2011 he was awarded the Military Civilian Partnership Award for ‘Regular of the Year’, as well as receiving the Wounds UK ‘Key Contribution’ award and the Smith and Nephew ‘Customer Pioneer of the Year’ award. He has also been awarded Fellowship of the Royal College of Surgeons of England ad eundum. He is an expert adviser to NICE Medical Technologies Evaluation Programme. Steve co-founded the Woundcare 4 Heroes charity, which is already making a big difference to the wound care of both serving and veteran personnel.

Dr Matthew Bayfield

Medical Specialist Scientific Director

Dr Matthew Bayfield, Head of Cardiothoracic Surgery, Strathfield Private Hospital and VMO Cardiothoracic Surgeon, Royal Prince Alfred Hospital.

Professor Peter Windsor

Veterinarian Research Advisor

Peter is a registered specialist veterinary surgeon in New South Wales and an emeritus Professor at Sydney University. He holds a BVSc (Hons), PhD, DVSc and diploma from the European College of Small Ruminant Health Management.

Dr Julian Braidwood

Global Regulatory Affairs Advisor

Julian has held leadership roles and managed international clinical projects with Grampian. He was previously Regulatory Affairs Manager at Novartis Animal Health. He is the Founder and Managing Director of Triveritas, where he is responsible for a team of 40 animal health specialists across the EU and the US.

Tri–Solfen^®

Tri-Solfen^® is a local anaesthetic and antiseptic gel spray that adheres well to wounds and acts as a barrier to environmental stimuli, promotes haemostasis and improves wound healing. Tri-Solfen^® contains two proven topical local anaesthetics; fast-acting Lignocaine for immediate pain relief and long-acting bupivacaine for prolonged post-operative pain relief. Adrenaline is included for its ability to reduce the shock and stress of blood loss, whilst prolonging the anaesthetic action. Tri-Solfen^® also contains Cetrimide; an antiseptic widely used to cleanse skin and wounds and provides protection from bacterial contamination.

Proven, affordable and practical pain relief solution for surgical and accidental wounds in all animal species

Tri-Solfen^®

Innovation in pain relief

Tri-Solfen^® is a Veterinarian prescribed, farmer applied pain relief product sprayed directly onto the wound during surgical procedures such as castration, tail docking and disbudding. The product is designed to provide an adhesive barrier over the wound, numbing the area and minimising bleeding whilst providing protection against infection.The use of Tri-Solfen^® is recommended by leading livestock industries, international retailers, animal welfare groups (including the RSPCA and CIWF) and highly respected welfare scientist such as Temple Grandin and Professor Peter Windsor. There has been over 150 million animals successfully treated with Tri-Solfen^® addressing the urgent needs of producers and their customers to improve animal welfare outcomes. Pain management in livestock production is top of mind for many producers who want to improve animal welfare outcomes, for veterinarians who have the difficult task to help producers to improve welfare standards in a practical and cost effective manner and for consumers and governments that are increasingly demanding the improved humane treatment of animals. This has lead to livestock supply chains globally creating and enforcing new strict animal welfare codes with large retailers requiring producers to implement practices to improve the wellbeing of animals including the alleviation of pain. Currently available pain treatments are either costly or impractical for use, disrupting management practices. Tri-Solfen^® is an innovative solution developed with producers and their animals in mind providing a practical solution for improved animal welfare outcome.

“A breakthrough for all livestock farmers around the World – finally a common sense approach to a highly complex issue”

Dr. Peter Windsor D.V.M. Ph.DSydney University

Tri-Solfen^® at a glance

Cost effective
Practical application
Single dose via topical application applied by the farmer. No need to double handle livestock
Known active ingredients
Over 150 million animals safely treated
36 patents granted globally including the USA and EU
16 independent published studies
Confirming safety and efficacy in pigs, cattle and sheep
EU, USA and Canadian Marketing approvals commenced
Designed for rapid onset (1 minute) and prolonged effect (24 hours)
Added benefits
Reduced bleeding, promotes wound healing, reduces infection risk and improves animal well-being
Accepted by all stakeholders
Including retailers animal welfare groups and animal welfare scientist
Proven
Highly effective for castration and tail docking in all species including pigs and cattle

Download Tri-Solfen^® Factsheet

Product composition

Lignocaine/Bupivacaine

Commonly used, safe, well documented
Rapid onset (1-3 minutes) and prolonged analgesic effect

Adrenaline

Constricts blood vessels, reduces blood loss
Concentrates local action of lignocaine, increases prolonged effect and decreases risk of toxicity

Antiseptic Agent

Reduces and prevents risk of infection. Mitigates the need to apply routine antibiotic applications

Spray & stay viscous solution

Easy application
Maximium wound adhesion
Creates protective barrier over the wound

Video

Tri-Solfen^® has changed wound care in animals

Meredith Sheil invented Tri-Solfen^®. Her career was originally in paediatric cardiac research before she spotted a need for better treatment of animals, and recognising how human medicine could benefit livestock and farming practices. The work she and Medical Ethics have done in the area of animal wound care is now one of the products leading the way for animal welfare.

Watch more videos

Testimonials

Patent Portfolio